Mirae Asset Global Investments Co., Ltd. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$876,908
-5.9%
91,060
+3.9%
0.00%0.0%
Q2 2023$932,312
+2.2%
87,600
+1.0%
0.00%0.0%
Q1 2023$912,074
+16.5%
86,699
+37.3%
0.00%0.0%
Q4 2022$782,652
+19.7%
63,168
+0.1%
0.00%0.0%
Q3 2022$654,000
+24.1%
63,110
+38.1%
0.00%
+100.0%
Q2 2022$527,000
-54.0%
45,700
-39.0%
0.00%
-96.2%
Q4 2016$1,145,000
+30.7%
74,858
+35.8%
0.03%
+44.4%
Q3 2016$876,000
+21.2%
55,136
-0.2%
0.02%
-5.3%
Q2 2016$723,000
-47.3%
55,259
-56.0%
0.02%
-48.6%
Q1 2016$1,373,000
-3.8%
125,484
+1.9%
0.04%
-21.3%
Q4 2015$1,427,000
+12.4%
123,127
+1.1%
0.05%
-9.6%
Q3 2015$1,270,000
-10.9%
121,843
+3.1%
0.05%
+13.0%
Q2 2015$1,425,000
-11.0%
118,188
+18.1%
0.05%
-14.8%
Q1 2015$1,602,000
+29.0%
100,100
+23.5%
0.05%
+20.0%
Q4 2014$1,242,000
+15.6%
81,078
-2.2%
0.04%
+15.4%
Q3 2014$1,074,00082,9080.04%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders